OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MICA/B-targeted antibody promotes NK cell–driven tumor immunity in patients with intrahepatic cholangiocarcinoma
Barbara Oliviero, Stefania Varchetta, Dalila Mele, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 91

Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 19

Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications
Jie Wang, Yian Wang, Xianjie Jiang, et al.
Cancer Letters (2024) Vol. 588, pp. 216758-216758
Closed Access | Times Cited: 14

Heterogeneity of Cholangiocarcinoma Immune Biology
Francesca Vita, Irene Olaizola, Francesco Amato, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 846-846
Open Access | Times Cited: 20

Immunomodulatory role of metalloproteinase ADAM17 in tumor development
Kai Wang, Zixue Xuan, Xiaoyan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26

Genetically druggable targets for MAPK-activated colorectal cancer by a two-sample mendelian randomization analysis
Yuxuan Zhou, Yunlong Ding, Binghe Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Natural killer cells at the forefront of cancer immunotherapy with immune potency, genetic engineering, and nanotechnology
Weiyi Pan, Tao Tao, Yishu Qiu, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104231-104231
Closed Access | Times Cited: 9

Igniting cold tumors of intrahepatic cholangiocarcinoma: An insight into immune evasion and tumor immune microenvironment
Xueyin Zhou, Bin Zhang, Jiahao Hu, et al.
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100052-100052
Open Access | Times Cited: 3

Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)
Siqi Yang, Rui-Qi Zou, Yu-Shi Dai, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 6
Open Access | Times Cited: 8

Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes
Barbara Oliviero, Michele Dei, Aı́da Zulueta, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5

Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer
Huan Tian, Bugao Guan, Hongbo Li, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 5

Filamin A is involved in human intrahepatic cholangiocarcinoma aggressiveness and progression
Eleonora Vitali, Barbara Franceschini, Flavio Milana, et al.
Liver International (2023) Vol. 44, Iss. 2, pp. 518-531
Open Access | Times Cited: 5

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma
Xinjun Lu, Benjamin L. Green, Changqing Xie, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100723-100723
Open Access | Times Cited: 4

Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer
Luohang Ni, Jianing Xu, Quanpeng Li, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 941-963
Open Access | Times Cited: 1

Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells
Stefania Mantovani, Stefania Varchetta, Dalila Mele, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4060-4060
Open Access | Times Cited: 5

Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes.
Barbara Oliviero, Michele Dei, Aı́da Zulueta, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top